Sponsor Pipeline

Apellis Pharmaceuticals Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
4
Active Trials
2
Recruiting
1
Phase 3
Active Trials by Phase
Phase 3
1
Phase 2
2
Not specified
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT05809531 An Open-Label, Nonrandomized, Multicenter Extension Study to Evaluate the Long-term… C3G Active, Not Recruiting
Phase 2
NCT07215390 A Phase 2, Randomized, Placebo Controlled, Multicenter, Masked Study to Evaluate the… Geographic Atrophy Secondary to Age-related Macular Degeneration Recruiting
NCT04901936 A Study of Pegcetacoplan in Pediatric Patients With Paroxysmal Nocturnal Hemoglobinuria… Paroxysmal Nocturnal Hemoglobinuria (PNH) Recruiting
Not specified
NCT06161584 A Prospective, Multicenter, Open-Label, Observational Phase 4 Study to Evaluate… Geographic Atrophy Active, Not Recruiting
Get alerts when Apellis Pharmaceuticals's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free